BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9210914)

  • 1. Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia.
    Davidovitz Y; Ballin A; Meytes D
    Acta Haematol; 1997; 98(1):44-6. PubMed ID: 9210914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia.
    Rashid K; Ng R; Mastan A; Sager D; Hirschman R
    Leuk Lymphoma; 2005 Jul; 46(7):1051-5. PubMed ID: 16019557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues.
    Larsen CR; Hansen PB; Clausen NT
    Am J Hematol; 2002 May; 70(1):48-50. PubMed ID: 11994981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
    Hamblin TJ; Orchard JA; Myint H; Oscier DG
    J Clin Oncol; 1998 Sep; 16(9):3209-10. PubMed ID: 9738600
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
    Tertian G; Cartron J; Bayle C; Rudent A; Lambert T; Tchernia G
    Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia.
    Bergmann L; Fenchel K; Jahn B; Mitrou PS; Hoelzer D
    Ann Oncol; 1993 May; 4(5):371-5. PubMed ID: 8353071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia after fludarabine therapy].
    Tsuji T; Hirano T; Yamasaki H; Tuda H
    Rinsho Ketsueki; 2015 Jun; 56(6):705-10. PubMed ID: 26256883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
    Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
    N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections in patients with chronic lymphocytic leukemia treated with fludarabine.
    Anaissie EJ; Kontoyiannis DP; O'Brien S; Kantarjian H; Robertson L; Lerner S; Keating MJ
    Ann Intern Med; 1998 Oct; 129(7):559-66. PubMed ID: 9758577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia.
    Sezer O; Schmid P; Hallek M; Schweigert M; Beinert T; Langelotz C; Mergenthaler HG; Possinger K
    Ann Hematol; 1999 Oct; 78(10):475-7. PubMed ID: 10550560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
    Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
    Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
    [No Abstract]   [Full Text] [Related]  

  • 12. Fludarabine: risk factor for aggressive behaviour of squamous cell carcinoma of the skin?
    Herr D; Borelli S; Kempf W; Trojan A
    Ann Oncol; 2005 Mar; 16(3):515-6. PubMed ID: 15677626
    [No Abstract]   [Full Text] [Related]  

  • 13. Listeriosis after fludarabine treatment for chronic lymphocytic leukemia.
    Hequet O; de Jaureguiberry JP; Jaubert D; Gisserot O; Muzellec Y; Brisou P
    Hematol Cell Ther; 1997 Apr; 39(2):89-91. PubMed ID: 9168306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
    Wells T; Kovacs MJ
    Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Whipple's disease as a complication of chronic lymphocytic leukemia treated with fludarabine].
    Kuliszkiewicz-Janus M; Małecki R; Kuliczkowski K; Jeleń M
    Pol Arch Med Wewn; 2002 Sep; 108(3):887-91. PubMed ID: 12600186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC; Ma ES; Kwong YL
    Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
    Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T
    Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia.
    Hocepied AM; Falkson CI; Falkson G
    S Afr Med J; 1996 May; 86(5):549-50. PubMed ID: 8711555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia.
    Field K; Slavin MA; Seymour JF
    Eur J Haematol; 2002 Jul; 69(1):54-7. PubMed ID: 12270063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
    Myint H; Copplestone JA; Orchard J; Craig V; Curtis D; Prentice AG; Hamon MD; Oscier DG; Hamblin TJ
    Br J Haematol; 1995 Oct; 91(2):341-4. PubMed ID: 8547072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.